BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

GC Biopharma and Hanmi Pharmaceutical Receive FDA Clearance for Phase 1/2 Trial of First Once-Monthly Subcutaneous Treatment for Fabry Disease

Co-development of innovative new drug for the treatment of Fabry disease as "the world's first once-monthly subcutaneous treatment" Improves efficacy co...

September 04, 2024 | News

Hyundai Bioscience Advances Xafty® as Sole Oral COVID-19 Treatment for High-Risk Patients Ineligible for Paxlovid®

"Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patients who cannot take Paxlovid®" "While maintaining...

August 29, 2024 | News

Zuellig Pharma Secures Exclusive Distribution Agreement with Regeneron to Launch Libtayo® in South Korea and Taiwan

Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owne...

August 28, 2024 | News

Yunovia Gains MFDS Clearance for Phase 1 MAD Study of Oral GLP-1 Agonist for Diabetes and Obesity

Yunovia, a drug R&D subsidiary of Ildong Pharmaceutical Group, announced on the 26th that the Ministry of Food and Drug Safety (MFDS) of Korea has clea...

August 28, 2024 | News

South Korea's Seegene Develops Advanced Multiplex PCR Assays for Mpox and Other Viruses

Develops NovaplexTM MPXV/OPXV Assay and NovaplexTM HSV-1&2/VZV/MPXV Assay - Designed to detect four viruses at once using multip...

August 27, 2024 | News

CanariaBio Completes Enrollment for Phase 2 Study of Oregovomab with Chemotherapy in Advanced Ovarian Cancer

CanariaBio Inc, a leading late-stage biotechnology company, announces the successful completion of enrollment of 88 patients in a randomized Phase 2 study ...

August 26, 2024 | News

GE HealthCare and Roche Diagnostics Partner to Transform Precision Cancer Care in Asia Pacific

GE HealthCare and Roche Diagnostics have entered into a Memorandum of Understanding (MOU) that will leverage the strengths and resources of both comp...

August 22, 2024 | News

Samsung Biologics Joins PSCI to Enhance Responsible Supply Chain Management

Samsung Biologics to embed PSCI principles into business practices for responsible value chain management Supplier Partnership reaffirms company's commi...

August 07, 2024 | News

Bridge Biotherapeutics Completes Patient Enrollment for Phase 2 Study of BBT-877 in IPF Treatment

Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in South Korea developing novel drugs for fibrosis and cancer, an...

July 30, 2024 | News

Daewoong Pharmaceutical's Bersiporocin Shows Positive Safety Data in Phase 2 Trial for IPF

Daewoong Pharmaceutical (Co-CEOs Chang-Jae Lee and Seongsoo Park) announced a significant milestone in the development of 'Bersiporocin (DWN...

July 30, 2024 | News

GCCL Launches R&D Division to Bolster Biosimilar and Clinical Trial Analysis Services

Newly established R&D division this year is expected to provide full-scale in-house R&D in addition to clinical sample analysis Including blockb...

July 17, 2024 | News

Full-Life Technologies and SK Biopharmaceuticals Ink $571.5 Million Deal for Exclusive Rights to Radiopharmaceutical FL-091

Full-Life Technologies ("Full-Life"), a fully integrated global radiotherapeutics company, announced that it has entered into a license agreement wit...

July 17, 2024 | News

ADM Korea to Submit IND for Niclosamide-Based Combination Therapy for Prostate Cancer

IND for clinical study for combination therapy with hormone therapy in prostate cancer patients to be submitted in August, 2024. Niclosamide-based metab...

July 12, 2024 | News

Genexine Merges with EPD Bio to Advance Targeted Protein Degradation Technology

Merger with EPD Bio, a biotech developing a target protein degrader (TPD) platform technology Jaehyun Choi, Ph.D. founder and CEO of EPD Bio, join...

July 08, 2024 | News

Stay Connected